Page last updated: 2024-09-03

glabridin and Cancer of Liver

glabridin has been researched along with Cancer of Liver in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, MK; Chiou, HL; Hsieh, MJ; Lin, CW; Yang, SF1
Jiang, F; Li, Y; Li, Z; Mu, J; Ning, S; Si, L; Wang, X; Ye, X1
Chen, C; Chen, L; He, Z; Huang, G; Huang, Z; Li, B; Luo, S; Wan, Z; Wang, Z; Zhang, X1
Chen, CJ; Chen, MK; Chiou, HL; Chuang, YC; Hsieh, MC; Hsieh, MJ; Lo, YS; Yang, SF1

Other Studies

4 other study(ies) available for glabridin and Cancer of Liver

ArticleYear
Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-κB and AP-1 activity in human liver cancer cells.
    British journal of pharmacology, 2014, Volume: 171, Issue:12

    Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Humans; Isoflavones; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; Male; Matrix Metalloproteinase 9; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; NF-kappa B; Phenols; Phosphorylation; Signal Transduction; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Transcription Factor AP-1; Transcription, Genetic; Transfection; Xenograft Model Antitumor Assays

2014
The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells.
    PloS one, 2014, Volume: 9, Issue:5

    Topics: Antineoplastic Agents; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Isoflavones; Liver Neoplasms; MicroRNAs; Neoplastic Stem Cells; Phenols; Signal Transduction; Smad Proteins; Transforming Growth Factor beta

2014
Glabridin arrests cell cycle and inhibits proliferation of hepatocellular carcinoma by suppressing braf/MEK signaling pathway.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Division; Computational Biology; Drug Design; Hep G2 Cells; Humans; Isoflavones; Liver Neoplasms; MAP Kinase Kinase 1; MAP Kinase Signaling System; Models, Molecular; Phenols; Phosphorylation; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins B-raf; Tumor Stem Cell Assay

2016
Glabridin induces apoptosis and autophagy through JNK1/2 pathway in human hepatoma cells.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2016, Apr-15, Volume: 23, Issue:4

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Carcinoma, Hepatocellular; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Glycyrrhiza; Humans; Isoflavones; Liver Neoplasms; MAP Kinase Signaling System; Membrane Proteins; p38 Mitogen-Activated Protein Kinases; Phenols; Phytotherapy; Plant Extracts; Signal Transduction

2016